Trend-Following Backtester · Guide · backtest 한국어

equity · KR

엘앤씨바이오 backtest

10 trend-following strategies were compared on the full daily history of 엘앤씨바이오. 8 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 30.3%, MDD -40.5%).

Data 2018-11-01 ~ 2026-07-31daily bars 1,899 (7.7 years)Costs 0.5%Venue XKOSMonthly snapshot 2026-07-31

Results by strategy

8 of 10 beat buy and hold (CAGR 25.3%, drawdown -70.6%).

Sharpe leader (same as main): Supertrend — CAGR 40.7%, MDD -54.8%, Sharpe 1.04, 44% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 15.4%p higher than buy and hold, while drawdown improves by 15.8%p (CAGR 30.3%, MDD -40.5%, exposure 39%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=19, mult=2.1
40.7%-54.8%1.040.7414.1x6844%
SMA 크로스오버
fast=65, slow=129
36.4%-57.8%0.900.6311.1x1250%
EMA 크로스오버
fast=13, slow=56
34.2%-47.3%0.860.729.8x4252%
Keltner 채널 돌파
emaPeriod=46, atrPeriod=20, mult=1.5
30.3%-40.5%0.840.757.8x4039%
Parabolic SAR
step=0.02, maxStep=0.2
28.4%-52.7%0.810.546.9x14648%
ROC 모멘텀
n=81, threshold=-0.01
31.0%-56.3%0.810.558.1x7854%
볼린저 밴드 돌파
n=11, k=1.4
24.5%-56.7%0.770.435.5x13835%
Donchian 채널 돌파
entryN=38, exitN=74
28.7%-61.5%0.750.477.1x1470%
ADX / DI 방향성
period=19, threshold=11
26.9%-58.3%0.750.466.3x9456%
MACD
fast=9, slow=23, signal=10
24.4%-70.4%0.730.355.4x15849%
Buy and hold25.3%-70.6%0.680.365.7x1100%
1x 10x 2019 2020 2021 2022 2023 2024 2025 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -18% -35% -53% -71% 2019 2020 2021 2022 2023 2024 2025 2026 Buy and holdSupertrend
Supertrend maximum drawdown -54.8% (2020-08-10 → 2024-12-04), recovered after 1,859 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next